Cargando…
Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035544/ https://www.ncbi.nlm.nih.gov/pubmed/36968810 http://dx.doi.org/10.1159/000529667 |
_version_ | 1784911434996514816 |
---|---|
author | Huerva, Valentín Vilardell, Felip Cid-Bertomeu, Pau |
author_facet | Huerva, Valentín Vilardell, Felip Cid-Bertomeu, Pau |
author_sort | Huerva, Valentín |
collection | PubMed |
description | When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM of the right eye involving the inferior tarsal conjunctiva, fornix, and inferotemporal bulbar conjunctiva. Histological study showed a PAM with atypia (C-MIN 5). Given the extent of the lesion and its location, a wide mutilating excision was ruled out. Topical interferon alpha 2b (IFN-α2b) treatment (1,000,000 IU/mL, 4 times a day) was administered during 10 weeks. However, the regression was very slow. Then local cryotherapy was proposed (8 s at −80°C per application) to the entire pigmented lesion. This afforded progressive depigmentation, which was completed 2 months later. No recurrence of the lesion has been noted during 3 years of follow-up. The combination of the two procedures reduces IFN-α2b eyedrop administration time, enhancing patient compliance. The combination may eradicate the tumor without compromising ocular cosmesis. |
format | Online Article Text |
id | pubmed-10035544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-100355442023-03-24 Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis Huerva, Valentín Vilardell, Felip Cid-Bertomeu, Pau Case Rep Ophthalmol Case Report When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM of the right eye involving the inferior tarsal conjunctiva, fornix, and inferotemporal bulbar conjunctiva. Histological study showed a PAM with atypia (C-MIN 5). Given the extent of the lesion and its location, a wide mutilating excision was ruled out. Topical interferon alpha 2b (IFN-α2b) treatment (1,000,000 IU/mL, 4 times a day) was administered during 10 weeks. However, the regression was very slow. Then local cryotherapy was proposed (8 s at −80°C per application) to the entire pigmented lesion. This afforded progressive depigmentation, which was completed 2 months later. No recurrence of the lesion has been noted during 3 years of follow-up. The combination of the two procedures reduces IFN-α2b eyedrop administration time, enhancing patient compliance. The combination may eradicate the tumor without compromising ocular cosmesis. S. Karger AG 2023-03-22 /pmc/articles/PMC10035544/ /pubmed/36968810 http://dx.doi.org/10.1159/000529667 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Huerva, Valentín Vilardell, Felip Cid-Bertomeu, Pau Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title | Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title_full | Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title_fullStr | Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title_full_unstemmed | Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title_short | Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis |
title_sort | cryotherapy after topical interferon alpha 2b to treat conjunctival primary acquired melanosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035544/ https://www.ncbi.nlm.nih.gov/pubmed/36968810 http://dx.doi.org/10.1159/000529667 |
work_keys_str_mv | AT huervavalentin cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis AT vilardellfelip cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis AT cidbertomeupau cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis |